Oral squamous cell cancer: early detection and the role of alcohol and smoking by Zygogianni, Anna G et al.
REVIEW Open Access
Oral squamous cell cancer: early detection and
the role of alcohol and smoking
Anna G Zygogianni
1*, George Kyrgias
2, Petros Karakitsos
3, Amanta Psyrri
4, John Kouvaris
1, Nikolaos Kelekis
1,
Vassilis Kouloulias
1
Abstract
Objective: Oral squamous cell carcinoma has a remarkable incidence worldwide and a fairly onerous prognosis,
encouraging further research on factors that might modify disease outcome.
Data sources: A web-based search for all types of articles published was initiated using Medline/Pub Med, with
the key words such as oral cancer, alcohol consumption, genetic polymorphisms, tobacco smoking and prevention.
The search was restricted to articles published in English, with no publication date restriction (last update 2010).
Review Methods: In this review article, we approach the factors for a cytologic diagnosis during OSCC
development and the markers used in modern diagnostic technologies as well. We also reviewed available studies
of the combined effects of alcohol drinking and genetic polymorphisms on alcohol-related cancer risk.
Results: The interaction of smoking and alcohol significantly increases the risk for aero-digestive cancers. The
interaction between smoking and alcohol consumption seems to be responsible for a significant amount of
disease.
Conclusion: Published scientific data show promising pathways for the future development of more effective
prognosis. There is a clear need for new prognostic indicators, which could be used in diagnostics and, therefore a
better selection of the most effective treatment can be achieved.
Introduction
In the past, squamous cell carcinoma of the oral cavity
(OSCC) was primarily found in elderly men with the
risk factors being tobacco and excessive alcohol use.
However, some studies have shown an increased inci-
dence of OSCC among young patients under 40 years of
age [1]. According to Llewellyn et al and Manuel S et al
recent case-control studies there are controversial
results concerning the possible differences in the etiol-
ogy and biological nature of OSSC between young and
elderly patient groups. The two studies have indicated
that OSCC is a similar disease in the age groups under
and over 40 years [2,3].
Primary OSCC is treated by surgery with or without
neck dissection, or by combined surgery and radiother-
apy. Despite the radical nature of the treatment,
recurrences are common [4]. There is a clear need for
new prognostic indicators, which could be used in diag-
nostics and, consequently, in the selection of the most
effective treatment method [5].
Methods
A web-based search for all types of articles published
was initiated using Medline/Pub Med, with key words
such as oral cancer, alcohol consumption, genetic poly-
morphisms, tobacco smoking and prevention. The
search was subsequently refined. The sites of specialized
scientific journals in the areas of oral and maxillofacial
surgery, oral medicine, and oncology were also used.
We give an overview of published studies on the com-
bined effects of alcohol drinking, smoking and poly-
morphisms in genes for alcohol dehydrogenase (ADH),
aldehyde dehydrogenase (ALDH), cytochrome P450 2E1,
and methylene-tetrahydrofolate reductase on the risk of
alcohol-related cancer. Other available data are insuffi-
cient or inconclusive and they highlight the need for
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published in English, with no publication date restriction
(last update 2010).
Review of the literature
Patient related factors
There are no prognostic differences between males and
females, although some authors have reported lower
survival rates in females, attributed to delay in seeking
medical care and lower acceptance of treatment [6,7].
The correlation of prognosis with age seems controver-
sial, and some authors show no relationship between
them, whereas others demonstrate worse prognosis in
older patients [8]. Another possible theory is that
patients with more hostile tumours develop symptoms
earlier, so they seek medical attention sooner; neverthe-
l e s s ,t h e s ep a t i e n t ss t i l lh a v et of a c eam o r eg r i e v o u s
outcome, because these malignancies display a more
aggressive biologic behaviour [9].
Genetics
Fialka F et al in a microarray-based gene-expression
analysis found 601 genes to be significantly regulated in
cancer tissue compared to adjacent intra-individual
mucosa controls, and 25 genes with differences in their
regulation comparing samples from early-stage cancer
with the ones from advanced disease. Genes FMO2,
CPA6, TNC, and SIAT1 were significantly up regulated
in early disease stages, and LGI1 gene expression was
significantly enhanced in normal adjacent mucosa of
patients with early-stage disease without showing a
differential expression in carcinoma biopsies [10].
Chiang WF et al have established the amplification,
mutation and expression of one gene - epidermal
growth factor receptor (EGFR) - in areca-associated oral
squamous cell carcinoma, showed amplifications of
EGFR in 33% of cases. Significant increases in EGFR
copy number and EGFR immunoreactivity were found
in OSCC compared with matched adjacent oral mucosa,
suggesting that genomic amplification could be a genetic
basis underlying activation of the EGFR pathway in
areca-associated OSCC [11].
A study of Hatagima A et al of genetic polymorphisms
of the carcinogen-metabolising enzyme Glutathione-S-
transferase at GSTM1, GSTT1, and GSTP1 gene loci on
OSCC susceptibility among Brazilians did not support
the hypothesis of an increased risk of GSTP1 G/G,
GSTM1 or GSTT1 null genotypes for developing OSCC:
rather the GSTM1 A/B genotype emerged as a protec-
tive factor [12].
The research of Serefoglou Z et al has indicated func-
tional polymorphisms affecting gene expression of inter-
leukins IL-4, -6, -8, and -10 as well as tumour necrosis
factor-alpha (TNF-a), are strongly associated with an
increased risk for OSCC [13]. Smokeless tobacco has
been shown to induce TNF-a,w h i c h ,a l o n gw i t hi t s
receptors, is over-expressed in OSCC. Single nucleotide
polymorphisms (SNPs) in TNF-a and TNF receptor
genes may affect their expression and may be a potential
determinant of susceptibility to tobacco-related OSCC.
TNF-a -308 G allele was significantly lower, whereas A
allele was significantly higher in OSCC patients com-
pared with controls. Both TNFR1 -609 TT and TNFR2
1690 CT genotypes were significantly lower in OSCC
patients compared with controls. It seems that TNF-a
-308 G/A may be related to susceptibility, whereas -609
TT TNFR1 and 1690 C/T TNFR2 SNPs may be protec-
tive to tobacco-related OSCC [14].
Lin YC et al focused on polymorphisms of COX-2
-765 G > C. The frequency of COX-2 -765 G/G geno-
type was significantly higher in healthy controls. COX-2
-765 C allele vs. -765 G/G genotype was a protective
factor against OSCC development, but was a risk factor
for malignant potential of oral potentially malignant dis-
orders. Polymorphisms of p53 codon 72 were not asso-
ciated with OSCC development and malignant potential
of oral potentially malignant disorders [15].
Functional DNA repair genes are essential for the pro-
tection against carcinogenesis. Study of the DNA repair
gene ERCC6, produced results suggesting that the het-
erozygous and homozygous A allele of the ERCC6
codon 399 may be associated with the development of
OSCC. Those who had homozygous A/A or heterozy-
gous A/G at ERCC6 codon 399 showed increased risk
of OSCC compared to those with G/G. As for ERCC6
codon 1097 or 1413, there was no difference in distribu-
tion between the OSCC and control groups [16].
Study of the DNA double-strand break repair gene
XRCC4, found a significant different distribution in the
frequency of the XRCC4 intron 3 genotype, but not the
XRCC4 G-1394T or intron 7 genotypes, between OSCC
and control groups. Chiu CF et al observed that those
who had heterozygous del/ins at XRCC4 intron 3
showed increased risk of OSCC compared the ones with
ins/ins. As for XRCC4 G-1394T or intron 7 polymorph-
isms, there was no difference in the distribution between
OSCC and control groups. There were significant gene-
environment interactions between XRCC4 intron 3 gen-
otype with smoking and with betel quid chewing, but
not with alcoholism. In smoker and betel quid chewer
groups, the XRCC4 intron 3 del variants exhibited
higher risks than the ins genotype, respectively. These
results suggest that the XRCC4 intron 3 del genotype
may be associated with OSCC [17]. Individuals who car-
ried at least one C allele (T/C or C/C) of the DNA
repair gene Ku70 promoter T-991C had an increased
risk of developing OSCC compared to those who carried
the T/T wild-type genotype but neither the Ku70
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connected to OSCC susceptibility [18].
Coutinho-Camillo CM et al showed the involvement
of th Bcl-2 family proteins in OSCC tumorigenesis and
suggests that the expression of apoptotic molecules
might be used as a prognostic indicator for OSCC. Two
hundred and twenty nine cases of OSCC, arranged in a
tissue microarray, were immunohistochemicallyanalysed
[19].
Recently Chaudhary A et al focused in matrix metallo-
proteinases(MMPs), enzymes that degrade all the com-
ponents of extra cellular matrix and collagen. They
studied 362 patients with oral submucous fibrosis
(OSMF)and head and neck lesions and they concluded
that the expression of MMP-3 genotype associated with
5A alleles may have an important role in the susceptibil-
ity of the patients to develop OSMF and head and neck
squamous cell carcinoma [20].
The effectiveness of tight junction proteins (claudins
1, 4, 5, 7 and occludin) and cancer associated fibroblasts
(CAFs) as prognostic markers in OTSCC and as mar-
kers of malignancy in ameloblastomas was studied by
Bello I et al. Abundance of CAFs and Claudin 7
derangement was found to be associated with poor dis-
ease-specific survival in oral (mobile) tongue cancer.
Appearance of CAFs within the epithelial islands of
ameloblastoma was found to be a marker of malignancy
in the tumor. The prognostic predictability of CAF den-
sity, Ki-67 (cell proliferation marker), maspin (tumor
suppressor marker) and tumor DNA content (tumor
ploidy using image cytometry) in tongue cancers was
also tested. CAF density was the only marker strongly
predictive of prognosis. In ameloblastomas, a-SMA (for
CAFs), Ki-67, epithelial membrane antigen (EMA) and
DNA content (using image and flow cytometry) were
assessed as markers of ameloblastic carcinoma. Only a-
SMA was able to predict ameloblastic carcinoma when
it was found in the epithelial islands. In conclusion,
staining for a-SMA and claudin 7 seems to be beneficial
for prognostication in tongue cancer, while a-SMA
staining may be beneficial in differentiating ameloblas-
toma from ameloblastic carcinoma [21].
Alcohol consumption
Several researchers [22,23] have reviewed the effects of
alcohol-drinking on cancer risk. Ethanol in alcoholic
beverages has been classified as carcinogenic to human
beings. A causal link has been established between alco-
hol consumption and cancer of the upper aero digestive
tract (i.e., of the oral cavity, pharynx).
Ethanol is absorbed by the small intestine and later
metabolised, mainly in the liver. Alcohol dehydrogenases
(ADH) are cytosolic, dimeric, zinc-containing NAD-
dependent enzymes that oxidise ethanol into acetaldehyde.
When alcohol consumption is high, the cytochrome P450
2E1 (CYP2E1, a member of the cytochrome P450 super-
family) can also catalyse ethanol into acetaldehyde while
producing reactive oxygen species (ROS) [24]. Subse-
quently, acetaldehyde is converted into acetate by aldehyde
dehydrogenases (ALDH). Although there are multiple
forms of ALDH in the liver, the enzyme encoded by
ALDH2 on chromosome 12 has a very low Michaelis con-
stant for acetaldehyde (about 1 μmol/L) and is thought to
oxidise most of the acetaldehyde generated during alcohol
metabolism.
Asakage T et al and Hiraki A et al with the observa-
tion [25,26] in Asian populations found a significantly
higher risk of cancer of the upper aerodigestive tract,
oral cavity or oropharynx, and hypopharynx in moderate
or heavy drinkers carrying the ADH1B*1/*1 genotype. In
particular, a gene-environment interaction between
ADH1B polymorphism and alcohol-drinking was signifi-
cant (p = 0·035): risk of cancer of the upper aerodiges-
tive tract in heavy drinkers with a ADH1B*1/*1
genotype was higher than for heavy drinkers carrying
the ADH1B*2 allele. A recent multicentre study [27]
done in European countries by Hashibe M et al found a
protective effect of the ADH1B*2 allele in drinkers com-
pared with ADH1B*1/*1. Significantly reduced odds
ratios (OR) of 0·57 (95% CI 0·36-0·91) and 0·36 (0·17-
0·77) were recorded in never or moderate and in heavy
drinkers, respectively, who carried the ADH1B*2 allele.
These results are in agreement with the conclusions of a
pooled analysis [28] of three multicentre case-control
studies (n = 3876) of ADH, alcohol-drinking, and risk of
cancer of the upper aerodigestive tract: compared with
ADH1B*1/*1 never-drinkers, overall OR for moderate
drinkers carrying the *2 allele was 0·65 (0·50-0·85) and
for heavy drinkers carrying this allele was 0·42 (0·31-
0·56).
Overall, the results obtained for ADH1B polymorph-
isms do not concord with the so-called acetaldehyde
hypothesis that the ADH1B*1 allele (which encodes a
less-active enzyme, leading to lower acetaldehyde expo-
sure) should decrease the risk of cancer in drinkers. By
contrast, a decreased risk of cancer of the upper aerodi-
gestive tract was recorded in drinkers who carried the
ADH1B*2 allele that codes for the more-active enzyme.
The increased risk for ADH1B*1/*1 homozygotes might
result from an absence of alcohol flushing, enhancing
vulnerability to drinking and lifetime exposure to acetal-
dehyde, increasing the potential for so-called binge-
drinking, and longer exposure of the mucosa to ethanol
[29].
In the only available study by Risch A et al, concern-
ing the risk of laryngeal cancer, no significant associa-
tion was found for ADH1B genotype and alcohol
consumption in people of white ethnic origin [30].
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head and neck cancer in whites and Africans, two
[27,31] showed a significant modification of risk with
alcohol consumption. Peters and colleagues, regarded as
significant the interaction between alcohol consumption
and ADH1C genotype [31]. Odds ratio for cancer of the
upper aerodigestive tract in heavy drinkers with
ADH1C*2/*2 genotype was 7·1 (2·3-22·0) compared with
2·3 (1·4-3·8) for ADH1C homozygous wildtype (ie, *1)o r
heterozygous individuals. By contrast, a significantly
increased risk was noted for European moderate drin-
kers with ADH1C*1/*1 genotype compared with
ADH1C*2 allele carriers [27].
The study by Zavras et al showed an increased risk of
oral cancer for ADH1C*1/*2 heavy drinkers of white
ethnic origin [33]. For oral, oropharyngeal, and hypo-
pharynx cancers, the two [25,34] studies by Asakage T
et al and Bouchardy C et al that we identified were
inconsistent: in one study[34], the effects of ADH1C*1/
*1 genotype and lifetime alcohol consumption in white
individuals were associated with an increased risk; in
another study [25], the risk of oral, oropharyngeal, or
hypopharynx cancer were greater for Asians who were
moderate to heavy drinkers and of genotype ADH1C*1/
*2 or ADH1C*2/*2 than for Asians who were moderate
to heavy drinkers with ADH1C*1/*1 genotype.
The studies by Asakage T etal and Hiraki A et al
[25,26] of Asian populations and risk of cancer of the
upper aerodigestive tract, oral cavity, or oropharynx
found a significant interaction between ALDH2*1/*2
genotype and heavy (p = 0·013) or moderate to heavy
alcohol intake (p = 0·002). By contrast, another study
[35] found no significant modification of oral cavity can-
cer risk with alcohol consumption and ALDH2 poly-
morphism. In Europeans, in whom the ALDH2 mutant
allele at residue 487 is almost absent, a large multicentre
study [27] has shown a significantly increased risk of
cancer of the upper aerodigestive tract in individuals
who were heterozygous or homozygous for any ALDH2
variants at residues +84, +348, and -241 and who drank
moderately or heavily; a significant interaction was
noted between alcohol consumption and ALDH2 +348
and -241 polymorphisms [27].
For cancer of the upper aerodigestive tract, all studies
[25-27] identified showed increased risk in Asians who
were moderate or heavy drinkers and carriers of the
ALDH2*2 allele. These results are consistent with the
expected functional effect of the *2 variant: that reduced
ALDH2 activity decreases the elimination of acetalde-
hyde. Moreover, individuals with ALDH2 deficiency
have increased acetaldehyde levels in serum and saliva
than do those with ALDH2*1/*1 genotype, and
increased frequency of acetaldehyde adducts, sister chro-
matid exchanges, and micronuclei have been observed
in Asian drinkers with ALDH2*1/*2 genotype compared
with individuals with ALDH2*1/*1 genotype [24].
Two studies [34,35] have assessed the effect of
CYP2E1 polymorphisms and alcohol consumption. Bou-
chardy and colleagues[34] showed that in white popula-
tions, the highest risks of oral cavity or pharyngeal
cancer were recorded for the heaviest drinkers, with a
significant 7·2-times increased risk for carriers of
CYP2E1 c2 and a significant 2·5-times increased risk for
those of CYP2E1 c1/c1 genotype compared with moder-
ate drinkers with c1/c1 genotype. However, the small
number of carriers of CYP2E1 variant alleles has hin-
dered the interaction analysis [34].
Various studies[36-38] have assessed the relation
between MTHFR polymorphism at residue 677, alcohol
consumption, and cancer risk.
T h es t u d yb yS u z u k iTe ta l[ 3 6 ]h a v es h o w nt h a t
Asian heavy drinkers with MTHFR TT genotype had a
significantly decreased risk of head and neck cancer
compared with CT and CC genotypes. Significant inter-
actions between heavy drinking and residue 677 TT
genotype were observed for head and neck cancer
(p = 0·04) [36].
Another polymorphism has been related to modified
MTHFR activity [37]. A substitution of A to C at
nucleotide 1298 results in an aminoacid residue change
from glutamate to alanine. This polymorphism is asso-
ciated with reduced enzyme activity, but to a lesser
degree than is the MTHFR variant at residue 677. Indi-
viduals with the CC genotype at residue 1298 have 60%
of the enzyme activity of those with the AA genotype.
Capaccio and co-workers have shown that moderate
drinkers of white ethnic origin who are either double
heterozygous or double homozygous for MTHFR muta-
tions at residues 677 and 1298 had a higher risk of glot-
tic, supraglottic, and oropharyngeal cancer [38].
Alcohol and Cigarette smoking
It has long been recognized that there is a strong asso-
ciation between heavy alcohol use and cigarette smok-
ing. Approximately 80% of alcohol dependent patients
are reported to smoke cigarettes. [39]. In addition, nico-
tine dependence appears more severe in smokers with a
history of alcohol dependence [40].
The concomitant use of tobacco and alcohol contri-
butes to an increased incidence of several malignancies,
especially head and neck cancers. Men who both smoke
and drink are nearly 38 times more likely to develop
head and neck cancers than men who do neither [41].
Talamini et al. [42] observed a similar multiplicative
risk for laryngeal cancer with combined alcohol and
smoking exposure in European subjects. In addition,
prolonged alcohol consumption and smoking exposure
augments the risk for a second primary tumor in
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tumor [43].
Mutations in the p53 gene were present more often in
tumors from alcohol drinkers who smoked cigarettes
(76% of the 105 patients studied) than in nondrinkers
who smoked cigarettes (42% of the patients) or in non-
drinkers who did not smoke (14% of patients). A role
for p53 mutations in aerodigestive cancers in general
has been suggested by others [44,45].
Wallstrom P et al have observed that the high alco-
hol consumption and smoking in combination with
GSTM1 null genotype is associated with high titers of
plasma autoantibodies against the oxidized DNA base
derivative 5-hydroxymethyl-2’-deoxyuridine that is
used as a potential biomarker of cancer risk and oxida-
tive stress [46].
The cellular mechanisms impacted by combined
smoking and alcohol exposure are poorly understood,
but molecular epidemiology approaches are providing
insights regarding the importance of effects on oxidant/
antioxidant pathways and on metabolic pathways invol-
ving the cytochrome P450 system.
Cytochromes P450 (CYP) are enzymes (mixed func-
tion oxidases) that are predominantly expressed in the
liver and were recognized long ago as central in metabo-
lizing drugs, endogenous compounds, and environmen-
tal and dietary substances in humans. Specific CYP
enzyme activities are influenced by both ethanol and
smoking [47-49].
Miksys et al. [50] have reported that another member
of the cytochrome P450 family, CYP2B6, is increased in
various regions of the brains of smokers and alcoholics
with the potential role for the CC genotype contributing
to the highest levels of CYP2B6 protein.
Rodriquez M. et al observed that a statistically signifi-
cant relationship between smoking and loss of Methyl-
guanine-DNA-methyltransferase (MGMT) protein
expression. Loss of MGMT expression could be consid-
ered an early event in oral carcinogenesis with possible
prognostic implications [51].
Znaor A. et al conducted a case control study in
Chennai and Trivandrum, South India and they
observed a significant dose response on relation with
the duration and the amount of consumption of the
smoking, chewing and alcohol with the development of
the oral and pharyngeal carcinoma [41].
Nicotine and alcohol interactions within both the
developing and adult central nervous system (CNS) have
been the subject of much investigation and are reviewed
elsewhere [52,53]. Dopamine neurotransmission, parti-
cularly in the nucleus accumbens of the mesocorticolim-
bic system, is central to mechanisms regulating CNS
effects of both nicotine and alcohol. Each substance
works through different proteins and receptors
(classically, nicotinic acetylcholine receptors or nAChRs
for nicotine and N-methyl-D-aspartate or NMDA and
g-aminobutyric acid or GABA receptors for alcohol).
However, it is clear that ethanol also influences nAChR
activation and that nicotine can mediate dopamine-acti-
vating properties of alcohol [53,54]. In addition, there
is also a role for another important neurotransmitter,
serotonin, in the interactions between nicotine and alco-
hol within the CNS. It is anticipated that insights gained
from genetic studies will further enhance our under-
standing of how smoking and alcohol interact to influ-
ence CNS activity [53-55].
Viruses
A hospital-based case-control study by Pintos J et al in
Canada provided further evidence supporting a causal
association between human papillomavirus (HPV) infec-
tion and tonsil-related cancers. Cases consisted of newly
diagnosed patients with squamous cell carcinoma of the
oropharynx and OSCC. Controls were frequency
m a t c h e dt oc a s e so ng e n d e r ,a g e ,a n dh o s p i t a l .O r a l
exfoliated cells were tested for HPV DNA by the
PGMY09/11 polymerase chain reaction. Serum antibo-
dies against HPV 16, 18, and 31 viral capsids were
detected using immunoassay. HPV DNA was detected
in 19% of total cases, and 5% of controls but in 43% of
tonsil-related cancers (palatine tonsil and base of
tongue) [56].
An interesting anecdotal report showed a couple diag-
nosed synchronously with squamous cell carcinoma of
the head and neck where the tumours were positive for
HPV16 by PCR and both viral genomes were genetically
identical and closely related to HPV16R - the revised
European prototype. These tumours appeared to repre-
sent transmission between the couple [57].
Modern methods of oral cytology for OSCC
Cytomorphometry
The OralCDx BrushTest is a computer-assisted method
for the analysis of cellular samples collected using the
brush biopsy. Using a neural network-based image pro-
cessing system, this method can analyze digitalized
microscopic images of collected cells to detect oral pre-
cancerous and cancerous cells. OralCDx seems to have
a sensitivity and specificity of > 90% [58].
DNA image cytometry
DNA cytometry (figure 1.) is a method to measure DNA
ploidy. By comparing Feulgen dye-stained cytologic sam-
ples with normal epithelial cells, the malignancy of oral
mucosal cells can be determined.
Sudbo et al.[59] analyzed archival material and
reported that the nuclear DNA content of oral leukopla-
kia cells can be used to predict the risk of oral epithelial
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possible. In addition, a current study reported that pro-
moter hypermethylation was associated with head and
neck squamous cell carcinoma[60].
Using a DNA cytometric method, an increase in sensi-
tivity and specificity of the oral brush biopsy to 100% for
the early diagnosis of oral cancer was reported [61].
Optical diagnosis
An optical diagnosis was proven to be reliable. This was
an invasive technique for the detection of fluorescence in
tissues that arose from a photosensitizer. The use of
autofluorescence to detect malignant lesions emanated
from photodynamic therapy, a technique for cancer treat-
ment (figure 2). Autofluorescence describes the biologic
characteristic of tissues possessing endogenous fluoro-
phores such as flavin, tryptophan, elastin and collagen,
which become fluorescent when exposed to certain wave-
lengths of light. The presence of disease can change not
only the concentrations of these fluorophores but the
light-scattering and absorption properties of the tissue
too, owing to changes in blood concentration, nuclear
size distribution, collagen content and epithelial thick-
ness. The tissue is usually illuminated with a light source,
mostly in the near-ultraviolet to green range of the
spectrum.
Harris et al.[62] noted endogenous autofluorescence at
around 630 nm in tumors of the oral mucosa. However,
autofluorescence of normal tissues was also observed.
Porphyrin, which may rapidly accumulated in tumors
compared with the accumulation of the surrounding
normal tissue, it is the most commonly used target in
autofluorescence-detecting oncology. Moreover, por-
phyrin-based tumor detectio nm i g h to n l yb eu s e f u lf o r
diagnosing advanced tumors because of its high false-
positive potential.
Photodynamic diagnosis
Photodynamic diagnosis of an oral carcinoma and
precursor lesions mainly use 5-aminolevulinic acid
Figure 1 Flow cytometric analysis of cell cycle using a cocktail of FITC labeled cytokeratins (CK) and propidium iodine (PI).C e l l
populations are gated according to their CK positivity. DNA index (DI) and cell cycle phases (G0/G1, S, G2M) are analyzed for both CK positive
and CK negative cells (cytopathology department of ATTIKON university hospital).
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sensitizer and protoporphyrin IX (PpIX) which can be
administered systemically or applied topically to the oral
mucosa and facial skin. Excessive accumulation of
5-ALA-induced PpIX results in the accumulation of
intracellular porphyrins, especially PpIX, which increases
the tissue fluorescence.
Sharwani et al. [63] used 5-ALA in the form of a
mouth rinse to test 71 patients with clinical suspicion of
leukoplakia to identify dysplasia or carcinoma in situ
Figure 2 Poorly differentiated squamous cell carcinoma. ThinPrep
® smear of head and neck fine needle aspiration, pap stained ×400.
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city of 79-89%.
Chang et al [64] reported that a photodynamic diag-
nosis, photofrin, was used topically to detect early oral
cancer with a sensitivity of 92.45% in a macroscopic
study and 93.75% in a microscopic study. The epidermal
growth factor receptor (EGFR) is overexpressed in oral
cancer.
Soukos et al. [65] used an anti-EGFR monoclonal anti-
body coupled to the fluorescent dye, N, N_-di-carboxy-
pentyl-indodicarbocyanine-5,5_- disulfonic acid, to
detect a tumor-associated antigen of the EGFR. This
method using a specific antibody coupled with a fluores-
cent dye improved the detection accuracy to specificities
of 95.65% in the macroscopic study and 97.50% in the
microscopic study.
In addition, 5-ALA-induced PpIX accumulation might
lead to selective killing of macrophages at the site of
photodynamic treatment in OSCC56 and downregulate
the invasion.[66] Recent studies demonstrated improved
sensitivity and specificity, and the potential for the
immunophotodiagnosis of OSCC. (Table 1.)
An immunocytochemical analysis of oral brush biop-
sies can recognize atypical cells by detecting altered pro-
tein expressions by tumor cells. During the malignant
transformation of cells, the structure or expression level
of some proteins in the extracellular matrix (ECM) may
be altered. The transformation of squamous cell carci-
nomas with invasiveness and metastatic potential is
associated with a poor survival rate. The cell surface
molecules involved in cell migration and invasion might
be potential markers for monitoring malignant phenom-
ena. Franz M. et al reported that tenascin-C(L) and
laminin-5 g2 chain proteins have key functions in the
cascade of invasion and metastasis of OSCC.[67]. Their
expressions at both the messenger RNA and protein
levels are significantly high [68-70].
Chuang et al [71] reported that high podoplanin
expression was statistically significantly correlated with
clinical nodal metastasis. Some cytoplasmic proteins
which regulate oncogenic mechanisms may be potential
targets for early tumor detection or tumor recurrence.
The expression of serine protease inhibitor, clade B,
member 1(SERPINB1) was significantly higher in oral
cancer cells with high motility, and the overexpression
of SERPINB1 in invasive OSCC was clinicopathologically
confirmed [72]. Overexpression of PIN1, a prolyl iso-
merase which regulates phosphorylation of Ser/Thr- Pro
motifs, was associated with progression of OSCC [73].
Overexpression of hypoxia-inducible factor-1a (HIF-1a),
which reflects the presence of hypoxia, was correlated
with poor survival and tumor progression in patients
with OSCC [74-77]. In addition, messenger RNA
expression of annexin A1(ANXA1) was found in the
peripheral blood of patients with OSCC. A proteomics
approach demonstrated downregulation of ANXA1 in
OSCC-derived cell lines. More interestingly, the evi-
dence of nuclear localization of the ANXA1 protein
from the cytoplasm to nuclei was associated with poor
survival of patients with OSCC [78]. Marked downregu-
lation of plasma membranous ANXA1 was correlated
with the poorly differentiated status of OSCC cells
[79,80]. Monitoring of the nuclear translocation of
NXA1can be a potential marker for a diagnosis and
prognosis of OSCC. The receptor activator of nuclear
factor-B (RANK) and its ligand (RANKL), which are
involved in osteoclastogenesis leading to bony destruc-
tion, were potentially associated with bony invasion in
patients with OSCC [81].
Chiou et al. [82] found that enriched oral cancer
stem-like cells highly expressed stem/progenitor cell
markers such as Oct-4, Nanog, CD117, nestin, CD133
and ABCG2, and positive correlations of Oct-4, Nanog
and CD133 expressions with the tumor stage were
detected. The presence of typical cells may be correlated
with tumor progression.
T h ep r e v a l e n c eo fO S C Ci nt h eA s i a nc o u n t r i e si s
highly associated with betel quid chewing and smoking.
The genetic susceptibility to such environmental carci-
nogens and the resulting altered molecular expressions
might be potential markers for a diagnosis and prog-
nosis of OSCC [83]. Studies in patients with OSCC
Table 1 Modern methods of oral cytology for oral squamous cell carcinoma
Classification Analytic method Markers
Cytomorphometry Conventional cytologic diagnosis Cell morphology
Computer-assisted image Cell morphology
analysis (OralCDx)
DNA analysis DNA image cytometry DNA ploidy, DNA methylation
Optical diagnosis Autofluorescence Flavin, tryptophan, elastin,
collagen (endogenous fluorophores)
Photodynamic diagnosis 5-Aminolevulinic acid
Photofrin
Immunophotodiagnosis antibody targeting EGFR
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showed significantly altered expressions of genes and
proteins such as Her-2, highmolecular-weight microtu-
bule-associated protein 2 (hmw-MAP2), and increased
expressions of matrix metalloproteinase (MMP)-1 and
MMP-8, and increased activities of Src family kinases in
invasive tumor fonts86 and in smoking/betel-using
patients associated with somatic mitochondrial DNA
mutations [84-88].
In addition, chromosomal mutations as nuclear factor-
B promoter, deletion of chromosomes 4p and 9q asso-
ciated with poor outcomes of betel-using patients with
OSCC, and aberrant copy numbers of cyclin D1
(CCND1) and/or cortactin (CTTN) on chromosome
11q13 correlated to arecaassociated OSCC were also
reported. Combinational polymorphisms of DNA repair
genes of XRCC1, XRCC2, XRCC3, and XRCC4, and the
XRCC4 intron 3 delete genotype were highly associated
with people who have the betel nut chewing habit and
are susceptible to OSCC; in addition, the polymorphism
in the promoter of cyclooxygenase-2-1195A/A contribu-
ted to the development of betel-related OSCC [89-93].
Conclusions
The increasing incidence of SCC of the oral cavity in
the younger population, combined with an estimated
failure to improve survival rates and the evidence that
traditional risk factors may not be responsible for a pro-
portion of oral cancer cases in the young, demonstrate
the importance of a better understanding of oral cancer
epidemiology.
From this review it is clear that contrasting evidence
exists in literature as far as the status of alcohol and
tobacco as risk factors for oral carcinoma in young
adults are concerned. Many authors [22] have reported
that risk factors of smoking and drinking are considered
significant aetiological agents in older patients and they
are present to varying degrees in younger people.
Genetic studies by Tabor MP et al [94] have indicated
that patients diagnosed with SCC at a young age may
exhibit predispositions to genetic instability.
This literature review has demonstrated that there is a
paucity of research examining risk factors other than
alcohol and tobacco. This is probably due to the practi-
calities of asking patients about a plethora of possible
risk factors at the time of diagnosis. Despite the fact of
an absence of traditional factors in a significant propor-
tion of younger patients and the relatively short time
span for these behaviours, it is now important to exam-
ine the other potential risk factors, such as environmen-
tal carcinogens, stress, previous viral infections, and
familial episodes of cancer. Even if these agents are
proved to be unlikely risk factors in this population,
data collation is important in order to narrow the
possibilities. The factors underlying the disease in this
sub-group with no obvious risk factors will be difficult
to account for unless a thorough examination of all the
possible causes is undertaken.
One comment on the studies reviewed is the arbitrary
age cut off points used for inclusion into comparison
studies of ‘young people’. Not only do the age criteria
for young people vary between studies, they also lack
epidemiological characterization and this fact may be
responsible for blurring the boundaries between cancers
arising as a result of carcinogenic exposure to traditional
risk factors and the ones arising due to a genetic predis-
position or an acquired immuno-deficiency.
Despite the attainments already achieved concerning
OSCC diagnosis and therapy, mortality and morbidity
rates are still exceedingly high, challenging the available
methods of prognosis assessment and encouraging the
search for new and better markers, namely, molecular
markers that relate comprehensively with known altera-
tions of tumor progression.
The immense diversity found in the field of clinical
oncology must be considered from two main perspec-
tives: the biologic distinctiveness of each patient and the
biologic distinctiveness of each malignancy. In practical
terms, the factors with greater consensual influence on
disease outcome include disease staging, extracapsular
spread, tumor thickness and resection margin free of
disease. In the future, better results in clinical oncology
appear to rely on improved understanding of tumor
molecular biology.
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